Skip to content

DR. BEN BROOS, ENDOCRINOLOOG: what changed

BE 0765.877.752NACE 86.220, Specialist medical practiceOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€201,991
2024 · €198,035+€3,956
Equity
€638,774
2024 · €436,783+€201,991
Cash
€494,012
2024 · €357,389+€136,623
Balance sheet total
€643,212
2024 · €439,924+€203,288

Largest movements

2024 to 2025
Assets
  • Cash +€136,623

    up €136,623 (+38.2%), from €357,389 to €494,012

    mainly Net result for the year (+€201,991) and Receivables within one year (+€9,226)

  • Current investments +€50,000

    first reported in 2025, at €50,000

  • Tangible fixed assets +€21,426

    up €21,426 (+209%), from €10,236 to €31,662

  • Receivables within one year -€9,226

    down €9,226 (-97.4%), from €9,476 to €250

Equity and liabilities
  • Profit (loss) carried forward +€201,991

    up €201,991 (+47.3%), from €426,783 to €628,774

Income statement
  • Depreciation -€2,863

    down €2,863 (-45.3%), from €6,316 to €3,453

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €198,035
Gross operating margin +€1,239
Depreciation +€2,863
Other operating charges -€886
Financial income +€1,529
Financial charges -€75
Taxes -€713
Result 2025 €201,991
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€211,502
Investment -€74,879
Financing €0
Cash 2024 €357,389
Net result for the year +€201,991
Depreciation +€3,453
Receivables within one year +€9,226
Deferred charges and accrued income -€4,465
Smaller working-capital items +€60
Tax, wage and social debts +€1,237
Investment in fixed assets (net) -€24,879
Current investments -€50,000
Cash 2025 €494,012
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €439,924 €643,212 +€203,288 +46.2%
Fixed assets 21/28 €10,236 €31,662 +€21,426 +209%
Tangible fixed assets 22/27 €10,236 €31,662 +€21,426 +209%
Furniture and vehicles 24 €10,236 €31,662 +€21,426 +209%
Current assets 29/58 €429,688 €611,550 +€181,862 +42.3%
Amounts receivable within one year 40/41 €9,476 €250 -€9,226 -97.4%
Other amounts receivable 41 €9,476 €250 -€9,226 -97.4%
Current investments 50/53 - €50,000 +€50,000
Cash at bank and in hand 54/58 €357,389 €494,012 +€136,623 +38.2%
Deferred charges and accrued income 490/1 €62,822 €67,287 +€4,465 +7.1%
Total equity and liabilities 10/49 €439,924 €643,212 +€203,288 +46.2%
Equity 10/15 €436,783 €638,774 +€201,991 +46.2%
Contributions 10/11 €10,000 €10,000 = 0.0%
Profit (loss) carried forward 14 €426,783 €628,774 +€201,991 +47.3%
Amounts payable 17/49 €3,141 €4,437 +€1,297 +41.3%
Amounts payable within one year 42/48 €3,141 €4,437 +€1,297 +41.3%
Trade debts 44 - €107 +€107
Suppliers 440/4 - €107 +€107
Taxes, remuneration and social security 45 - €1,237 +€1,237
Taxes 450/3 - €1,237 +€1,237
Other amounts payable 47/48 €3,141 €3,094 -€47 -1.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €6,316 €3,453 -€2,863 -45.3%
Other operating charges 640/8 €648 €1,534 +€886 +137%
Gross operating margin 9900 €264,983 €266,222 +€1,239 +0.5%
Operating profit (loss) 9901 €258,020 €261,236 +€3,216 +1.2%
Financial income 75/76B €564 €2,093 +€1,529 +271%
Recurring financial income 75 €564 €2,093 +€1,529 +271%
Financial charges 65/66B €25 €100 +€75 +300%
Recurring financial charges 65 €25 €100 +€75 +300%
Profit (loss) for the period before taxes 9903 €258,559 €263,228 +€4,670 +1.8%
Income taxes 67/77 €60,524 €61,237 +€713 +1.2%
Profit (loss) for the period 9904 €198,035 €201,991 +€3,956 +2.0%
Profit (loss) for the period to be appropriated 9905 €198,035 €201,991 +€3,956 +2.0%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€906,941 to €1.1m

Midpoint €1.0m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €638,774
Capitalised earnings €1.2m to €1.6m
Indication €906,941 to €1.1m

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€638,774
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€638,774

Capitalised earnings

net result for the year (9904)
2025
€201,991
2024
€198,035
2023
€93,520
2022
€135,228
Average result
€164,515
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.2m / €1.4m / €1.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.